Jeon M - Search Results

1

Efficient access to highly pure β-amyloid peptide by optimized solid-phase synthesis.

Choi JW, Kim HY, Jeon M, Kim DJ, Kim Y. Choi JW, et al. Among authors: jeon m. Amyloid. 2012 Sep;19(3):133-7. doi: 10.3109/13506129.2012.700287. Epub 2012 Jul 16. Amyloid. 2012. PMID: 22799493

2

Therapeutic and pharmacokinetic characterizations of an anti-amyloidogenic bis-styrylbenzene derivative for Alzheimer's disease treatment.

Byeon SR, Kim HV, Jeon M, Ahn YG, Kim MS, Kong JY, Kim HY, Kim YS, Kim DJ. Byeon SR, et al. Among authors: jeon m. Bioorg Med Chem Lett. 2013 Jun 1;23(11):3467-9. doi: 10.1016/j.bmcl.2013.02.104. Epub 2013 Mar 13. Bioorg Med Chem Lett. 2013. PMID: 23601707

3

Development of a multi-functional concurrent assay using weak cation-exchange solid-phase extraction (WCX-SPE) and reconstitution with a diluted sample aliquot for anti-doping analysis.

Kim Y, Jeon M, Min H, Son J, Lee J, Kwon OS, Moon MH, Kim KH. Kim Y, et al. Among authors: jeon m. Rapid Commun Mass Spectrom. 2018 Jun 15;32(11):897-905. doi: 10.1002/rcm.8119. Rapid Commun Mass Spectrom. 2018. PMID: 29572989

4

A rapid non-target screening method for determining prohibited substances in human urine using liquid chromatography/high-resolution tandem mass spectrometry.

Han B, Min H, Jeon M, Kang B, Son J. Han B, et al. Among authors: jeon m. Drug Test Anal. 2019 Mar;11(3):382-391. doi: 10.1002/dta.2495. Epub 2018 Oct 25. Drug Test Anal. 2019. PMID: 30188018

5

Application of Skyline software for detecting prohibited substances in doping control analysis.

Lee HJ, Jeon M, Seo Y, Kang I, Jeong W, Son J, Yi EC, Min H. Lee HJ, et al. Among authors: jeon m. PLoS One. 2023 Dec 5;18(12):e0295065. doi: 10.1371/journal.pone.0295065. eCollection 2023. PLoS One. 2023. PMID: 38051722 Free PMC article.

6

Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in co-culture.

Kim SH, Choe C, Shin YS, Jeon MJ, Choi SJ, Lee J, Bae GY, Cha HJ, Kim J. Kim SH, et al. Anticancer Res. 2013 May;33(5):2001-9. Anticancer Res. 2013. PMID: 23645749

7

Activation of protein kinase Czeta mediates luteinizing hormone- or forskolin-induced NGFI-B expression in preovulatory granulosa cells of rat ovary.

Park JI, Kim SG, Chun JS, Seo YM, Jeon MJ, Ohba M, Kim HJ, Chun SY. Park JI, et al. Among authors: jeon mj. Mol Cell Endocrinol. 2007 May 30;270(1-2):79-86. doi: 10.1016/j.mce.2007.02.010. Epub 2007 Mar 12. Mol Cell Endocrinol. 2007. PMID: 17416458

8

Rh(III)-Catalyzed C-H Functionalization of Indolines with Readily Accessible Amidating Reagent: Synthesis and Anticancer Evaluation.

Jeon M, Mishra NK, De U, Sharma S, Oh Y, Choi M, Jo H, Sachan R, Kim HS, Kim IS. Jeon M, et al. J Org Chem. 2016 Oct 21;81(20):9878-9885. doi: 10.1021/acs.joc.6b02020. Epub 2016 Oct 3. J Org Chem. 2016. PMID: 27680096

9

Trifluoromethylallylation of Heterocyclic C-H Bonds with Allylic Carbonates under Rhodium Catalysis.

Choi M, Park J, Sharma S, Jo H, Han S, Jeon M, Mishra NK, Han SH, Lee JS, Kim IS. Choi M, et al. Among authors: jeon m. J Org Chem. 2016 Jun 3;81(11):4771-8. doi: 10.1021/acs.joc.6b00721. Epub 2016 May 23. J Org Chem. 2016. PMID: 27187625

10

Redox-Neutral Rh(III)-Catalyzed Olefination of Carboxamides with Trifluoromethyl Allylic Carbonate.

Park J, Han S, Jeon M, Mishra NK, Lee SY, Lee JS, Kwak JH, Um SH, Kim IS. Park J, et al. Among authors: jeon m. J Org Chem. 2016 Nov 18;81(22):11353-11359. doi: 10.1021/acs.joc.6b02485. Epub 2016 Nov 3. J Org Chem. 2016. PMID: 27794608

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,443 results

Search Page

Filters